Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors
Recruiting · NCT06950697 · Registry updated 2026-04-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Development and Application of a Thrombosis Risk Prediction Model in Lung Cancer Patients Treated With Immune Checkpoint Inhibitors | Embolism and Thrombosis, Neoplasms by Site, Thoracic Neoplasms, Thromboembolism, cardiovascular disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, vascular disorder, venous thromboembolism | Recruiting | Not stated | 2026-04-30 | NCT06950697 |
5 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Chaoyang Hospital, Capital Medical University | Beijing | China | 6 |
| Beijing Luhe Hospital, Capital Medical University | Beijing | China | 4 |
| China-japan friendship Hospital | Beijing | China | 24 |
| The First Affiliated Hospital of Zhengzhou University | Zhengzhou | China | 103 |
| The Fourth Hospital of Inner Mongolia Autonomous Region | Hohhot | China | 1 |